Consequences of a bipolar disorder and of use of mood stabilizers for pregnancy management;Consequenties van een bipolaire stoornis en gebruik van stemmingsstabilisatoren voor het beleid rond zwangerschap

Nederlands Tijdschrift voor Geneeskunde

Volumn 141, Issue 41, 1997, Pages 1960-1965

  Knoppert Van Der Klein, E A M ^a,b   Kolling P ^a,c   Van Gent, E M ^a,d   Van Kamp, I L ^a  

^a Psychiatrisch Ziekenhuis Endegeest   (Netherlands)

^b Twents Psychiatrisch Ziekenhuis   (Netherlands)

^c SLINGELAND HOSPITAL   (Netherlands)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; LITHIUM; VITAMIN K GROUP;

BIPOLAR DEPRESSION; DRUG SAFETY; DRUG TOXICITY; ELECTROCONVULSIVE THERAPY; GENETIC COUNSELING; HUMAN; PREGNANCY; SHORT SURVEY; ULTRASOUND;

ABNORMALITIES, DRUG-INDUCED; ADULT; BIPOLAR DISORDER; ELECTROCONVULSIVE THERAPY; FEMALE; GENETIC COUNSELING; HUMANS; INFANT, NEWBORN; POSTNATAL CARE; PREGNANCY; PREGNANCY COMPLICATIONS; PRENATAL CARE; PSYCHOTROPIC DRUGS; RISK ASSESSMENT;

EID: 0030761667     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (26)

1. Gent EM van, Nabarro G. Lithium en zwangerschap, psychiatrische aspecten. Ned Tijdschr Geneeskd 1984;128:2089-92.
2. Haaften M van, Bruinse HW. Lithium en zwangerschap; aanbevolen richtlijnen. Ned Tijdschr Geneeskd 1984;128:2103-5.
3. Klompenhouwer JL. Bipolaire stoornissen, erfelijkheid en psychosen in het kraambed. Cobo-bulletin 1995;28:29-32.
4. Gershon ES, Genetics. In: Goodwin FK, Jamison KR, editors. Manic-depressive illness. New York: Oxford University Press, 1990:373-401.
5. Mitchell P, Mackinnon A, Waters B. The genetics of bipolar disorder. Austr NZ J Psychiatry 1993;27:560-80.
6. Gent EM van. Lithiumgebruik tijdens zwangerschap. Cobo-bulletin 1994;27:15-22.
7. Altshuler LL, Cohen L, Szuba MP, Burt VK, Gitlin M, Mintz J. Pharmacologic management of psychiatric illness during pregnancy: dilemmas and guidelines. Am J Psychiatry 1996;153:592-606.
8. Steffelaar JW, Wesemael JWJ van. Anomalie van Ebstein van de tricuspidalisklep na expositie aan lithium voor de geboorte. Ned Tijdschr Geneeskd 1991;135:996-8.
9. Cohen LS, Friedman JM, Jefferson JW, Johnson EM, Weiner ML. A reevaluation of risk of in utero exposure to lithium. JAMA 1994; 271:146-50.
10. Jacobson SJ, Jones K, Johnson K, Ceolin L, Kaur P, Sahn D, et al. Prospective multicentre study of pregnancy outcome after lithium exposure during first trimester. Lancet 1992;339:530-3.
11. Cunnif CM, Sahn DJ, Reed KL, Chambers CC, Jolmson KA, Jones KL. Pregnancy outcome in women treated with lithium. Teratology 1989;39:447-8.
12. Collumbien ECA, Kock HCLV. Lithium en zwangerschap. De stand van zaken. Tijdschrift voor Psychiatrie 1993;35:601-11.
13. Jenniskens-Bruins JJ, Gerards LJ. Lithiumintoxicatie bij een pasgeborene. Tijdschr Kindergeneeskd 1992;60:76-8.
14. Oppen ACC van, Schobben AFAM, Oosterwijk JC, Elderson A, Keirse MJNC. Epilepsie en zwangerschap. Ned Tijdschr Geneeskd 1992;136:1290-4.
15. Jones KL, Lacro RV, Johnson KA, Adams J. Pattern of malformations in the children of women treated with carbamazepine during pregnancy. N Engl J Med 1989;320:1661-6.
16. Scolnik D, Nulman I, Rovet J, Gladstone D, Czuchta D, Gardner HA, et al. Neurodevelopment of children exposed in utero to phenytoin and carbamazepine monotherapy. JAMA 1994;1271:767-70.
17. Faedda GL, Tondo L, Baldessarini RJ, Suppes T, Tohen M. Outcome after rapid vs gradual discontinuation of lithium treatment in bipolar disorders. Arch Gen Psychiatry 1993;50:448-55.
18. Sachs GS. Bipolar mood disorder: practical strategies for acute and maintenance phase treatment. J Clin Psychopharmacol 1696;16(2 Suppl 1):32S-47S.
19. Miller LJ. Use of electroconvulsive therapy during pregnancy. Hosp Community Psychiatry 1994;45:444-50.
20. Gent EM van, Zwart FM. Lithiumcarbonate and lithiumcitrate, a comparison of the side effects of two slow-release lithium preparations. Acta Therapeutica 1987;13:291-7
21. Thiels C. Pharmacotherapy of psychiatric disorder in pregnancy and during breast feeding: a review. Pharmacopsychiatry 1987;20:133-46
22. Bialer M. Pharmacokinetic evaluation of sustained release formulations of antiepileptic drugs. Clinical implications. Clin Pharmacokinet 1992;22:11-21.
23. Sibbles BJ, Muinck Keizer-Schrama SMPF de, Anker JN van den. Auto-immuunziekten van de schildklier bij de moeder; gevolgen voor foetus en pasgeborene. Ned Tijdschr Geneeskd 1995;139:1113-6.
24. Klompenhouwer JL. Hulst AM van. Psychiatrische stoornissen bij kraamvrouwen. Ned Tijdschr Geneeskd 1994;138:1009-14.
25. Pop VJ, Vries E de, Baar AL van, Waelkens JJ, Rooy HA de, Horsten M, et al. Maternal thyroid peroxidase antibodies during pregnancy: a marker of impaired child development? J Clin Endocrinol Metab 1995;80:3561-6.
26. Lazarus JH, Hall R, Othman S, Parkes AB, Richards CJ, McCullosh B, et al. The clinical spectrum of postpartum thyroid disease. QJM 1996;89:429-35.